Taselisib (GDC-0032) is an orally bioavailable inhibitor of the class I phosphatidylinositol 3-kinase (PI3K) alpha isoform (PIK3CA), with potential antineoplastic activity.
Molecular Weight:
460.53
Purity:
98.92%
CAS Number:
[1282512-48-4]
Formula:
C24H28N8O2
Target:
PI3K|||Carbonic Anhydrase
T1999
* VAT and and shipping costs not included. Errors and price changes excepted